| Charles L Conlon, MD | |
|
16675 Southwest Fwy, #200, Sugar Land, TX 77479-2344 | |
| (281) 265-5454 | |
| (281) 265-5484 |
| Full Name | Charles L Conlon |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 16675 Southwest Fwy, Sugar Land, Texas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407956691 | NPI | - | NPPES |
| 135300508 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | E4266 (Texas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles L Conlon, MD 16675 Southwest Fwy, #200, Sugar Land, TX 77479-2344 Ph: (281) 265-5454 | Charles L Conlon, MD 16675 Southwest Fwy, #200, Sugar Land, TX 77479-2344 Ph: (281) 265-5454 |
News Archive
The University of Texas MD Anderson Cancer Center and BostonGene Corporation today announced a strategic alliance to advance the development and clinical integration of multiplatform biomarker signatures.
Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania to The Perryman Company, also headquartered in Houston, Pennsylvania. Substantially all of the Facility's employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.
Early rehabilitation interventions seem to be essential for how well a patient recovers after a severe brain injury. It might even increase the chances for long-term survival, according to researchers at the Sahlgrenska Academy.
Cipher Pharmaceuticals Inc. today announced that it has reached the enrollment mid-point in its Phase III safety study of CIP-ISOTRETINOIN, the Company's novel, patented formulation of isotretinoin, which is used in the treatment of severe, nodular acne. To date, more than 400 patients have been enrolled. Achieving this milestone triggers a US$2.0 million milestone payment from Ranbaxy Pharmaceuticals Inc., Cipher's U.S. marketing and distribution partner.
A 13-member surgical team from the Methodist DeBakey Heart & Vascular Center completed the first phase of training to implant a new total artificial heart designed to completely replace the heart's function while the patient waits for a heart transplant. Methodist will be the first hospital in Texas to offer this total heart replacement.
› Verified 9 days ago
Vandana Khera, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 18717 University Blvd Bldg 2, Suite 105, Sugar Land, TX 77479 Phone: 281-208-3322 Fax: 281-208-3393 | |
Susan Vijayan Mathew, DO Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16811 Southwest Fwy Fl 3, Sugar Land, TX 77479 Phone: 281-275-0897 | |
Saif K Altaie, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16655 Southwest Fwy, Sugar Land, TX 77479 Phone: 281-274-7000 | |
Priya N. Oolut, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16659 Southwest Fwy Ste 421, Sugar Land, TX 77479 Phone: 281-325-0005 Fax: 713-512-2247 | |
Dr. Htut Kyaw Win, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 16605 Southwest Fwy Ste 360, Sugar Land, TX 77479 Phone: 713-790-0841 Fax: 713-790-9963 | |
Cathlyn Anderson, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 15200 S Us 59 Highway Suite 360, Sugar Land, TX 75075 Phone: 832-237-3500 Fax: 832-237-0200 | |
Angela Denise Mcgee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11555 University Blvd, Sugar Land, TX 77478 Phone: 713-442-9100 |